Kazuyuki Kitatani

10PUBLICATIONS
19CO-AUTHORS
Epidemiological modellingLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)GlycoconjugatesAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 02, 2026
Dexrazoxane Protects Against Hand-Foot Syndrome-Like Skin Damage in Pegylated Liposomal Doxorubicin-Treated Mice.

Kentaro Nishida, Juna Tanaka, Chihiro Hashimoto

|Aug 12, 2025
Cyclin-dependent kinase (CDK) 8 and its paralog CDK19 develop group 2 innate lymphoid cell-related lung fibrosis by activating STAT5.

Masaya Matsuda, Yuna Fujiwara, Fumiya Yonezawa

|Feb 25, 2023
Ceramide Nanoliposomes as Potential Therapeutic Reagents for Asthma.

Harumi Sakae, Yuri Ogiso, Masaya Matsuda

|Nov 24, 2022
Extracellular Vesicles Derived from Allergen Immunotherapy-Treated Mice Suppressed IL-5 Production from Group 2 Innate Lymphoid Cells.

Masaya Matsuda, Seito Shimizu, Kazuyuki Kitatani

|Jan 10, 2021
Ceramide synthase 2-C24:1 -ceramide axis limits the metastatic potential of ovarian cancer cells.

Xuewei Zhang, Wataru Sakamoto, Daniel Canals

Pageof 2